Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * AMBOIAN JOHN P	2. Issuer Name and Ticker or Trading Symbol Danimer Scientific, Inc. [ DNMR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) C/O DANIMER SCIENTIFIC, INC., 140 INDUSTRIAL BOULEVARD	3. Date of Earliest Transaction (MM/DD/YYYY) 3/23/2021
(Street) BAINBRIDGE, GA 39817 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	$11.50	3/23/2021		J (1)		218335		5/8/2021	12/29/2025	Class A Common Stock ("Common Stock")	218335	(1)	218335	I	John P. Amboian 2008 Living Trust (1)
Warrants	$11.50	3/23/2021		J (2)		109168		5/8/2021	12/29/2025	Common Stock	109168	(2)	109168	I	Kings Trail Trust Dtd 09/19/2018 (2)

Explanation of Responses:
(1)	Represents the pro rata in kind distribution of all of the Warrants for the purchase of shares of Common Stock of the Issuer held by Live Oak Sponsor Partners, LLC (the "Sponsor"), without consideration, to its members. The John P. Amboian 2008 Living Trust (the "Living Trust") is a member of the Sponsor, and the Reporting Person is the sole trustee of the Living Trust and therefore the Reporting Person may be deemed to beneficially own the securities held by the Living Trust. The Reporting Person disclaims any beneficial ownership of the reported securities owned by the Living Trust other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
(2)	Represents the pro rata in kind distribution of all of the Warrants for the purchase of shares of Common Stock of the Issuer held by the Sponsor, without consideration, to its members. Kings Trail Trust Dtd 09/19/2018 (the "Kings Trail Trust") is a member of the Sponsor, and the Reporting Person's spouse is the sole trustee of the Kings Trail Trust and therefore the Reporting Person may be deemed to beneficially own the securities held by the Kings Trail Trust. The Reporting Person disclaims any beneficial ownership of the reported securities owned by the Kings Trail Trust other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
AMBOIAN JOHN P C/O DANIMER SCIENTIFIC, INC. 140 INDUSTRIAL BOULEVARD BAINBRIDGE, GA 39817	X

Signatures
/s/ John P. Amboian		3/25/2021
**Signature of Reporting Person		Date